Modulation of cardiac macrophages by phosphatidylserine-presenting liposomes improves infarct repair.
Herein we investigated a new strategy for the modulation of cardiac macrophages to a reparative state, at a predetermined time after myocardial infarction (MI), in aim to promote resolution of inflammation and elicit infarct repair. The strategy employed intravenous injections of phosphatidylserine (PS)-presenting liposomes, mimicking the anti-inflammatory effects of apoptotic cells. Following PS-liposome uptake by macrophages in vitro and in vivo, the cells secreted high levels of anti-inflammatory cytokines [transforming growth factor β (TGFβ) and interleukin 10 (IL-10)] and upregulated the expression of the mannose receptor--CD206, concomitant with downregulation of proinflammatory markers, such as tumor necrosis factor α (TNFα) and the surface marker CD86. In a rat model of acute MI, targeting of PS-presenting liposomes to infarct macrophages after injection via the femoral vein was demonstrated by magnetic resonance imaging (MRI). The treatment promoted angiogenesis, the preservation of small scars, and prevented ventricular dilatation and remodeling. This strategy represents a unique and accessible approach for myocardial infarct repair.
Avram and Stella Goldstein-Goren Department of Biotechnology Engineering, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.
Tamar
T
Harel-Adar
Tamar
T
Ben Mordechai
Yoram
Y
Amsalem
Micha S
MS
Feinberg
Jonathan
J
Leor
Smadar
S
Cohen
D000818:Animals; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005434:Flow Cytometry; D007150:Immunohistochemistry; D016753:Interleukin-10 / Q000378:metabolism; D008081:Liposomes; D008264:Macrophages / Q000378:metabolism / Q000502:physiology*; D051379:Mice; D008807:Mice, Inbred BALB C; D009203:Myocardial Infarction / Q000473:pathology*; D009206:Myocardium / Q000473:pathology*; D010718:Phosphatidylserines / Q000008:administration & dosage*; D051381:Rats; D017207:Rats, Sprague-Dawley; D016212:Transforming Growth Factor beta / Q000378:metabolism
D008081:Liposomes; D010718:Phosphatidylserines; D016212:Transforming Growth Factor beta; D016753:Interleukin-10
Nature. 2010 Jun 10;465(7299):697-9
20535192
J Exp Med. 2007 Nov 26;204(12):3037-47
18025128
Yale J Biol Med. 1971 Dec;44(3):286-300
5132788
J Leukoc Biol. 2004 May;75(5):828-35
14742636
Nat Rev Immunol. 2003 Jan;3(1):23-35
12511873
J Biol. 2004;3(4):15
15345036
Circulation. 2009 Dec 22;120(25):2559-66
19996019
Lancet. 2008 Jan 19;371(9608):228-36
18207018
J Am Coll Cardiol. 2005 Nov 15;46(10):1799-802
16286162
J Clin Invest. 2002 Jan;109(1):41-50
11781349
J Immunol. 1999 Jul 1;163(1):130-6
10384108
Circulation. 2007 Sep 11;116(11 Suppl):I38-45
17846324
Biochim Biophys Acta. 2003 Nov 20;1639(3):141-51
14636945
Kidney Int. 2007 Aug;72(3):290-9
17440493
J Biol Chem. 2006 Mar 3;281(9):5718-25
16317002
Int J Cardiol. 2008 Nov 12;130(2):147-58
18656272
Circulation. 2000 Nov 7;102(19 Suppl 3):III56-61
11082363
Nat Immunol. 2005 Dec;6(12):1179-81
16369556
Biochim Biophys Acta. 1991 Mar 18;1063(1):95-102
2015266
Cardiovasc Res. 2002 Jan;53(1):31-47
11744011
J Immunol. 1992 Apr 1;148(7):2207-16
1545126
J Cell Mol Med. 2009 Sep;13(9B):3485-96
19228260